cbdMD, Inc. — Form SCHEDULE 13D
Filed November 4, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D
— Neutral
significance 72/100
What the filing says
Akretive Holdings LLC (NY-based entity) filed Schedule 13D on Nov 4, 2026, indicating acquisition of beneficial ownership in cbdMD, Inc. The filing does not disclose the specific share count, percentage ownership, or dollar amount of the acquisition in the text provided. Without these core details, the precise impact cannot be quantified.
Why this rating
Schedule 13D filing signals 5%+ ownership threshold crossed, triggering disclosure—material for a $2.8M market-cap company. Specifics unavailable in text.
Price action (we called it neutral)
before filing · preread $0.38 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.